Notably, in cancers such as BRCA (Breast Cancer) and COAD (Colorectal Adenocarcinoma), a significant positive correlation exists between CD300E expression and M2 macrophages, typically associated with a tumor-promoting immunosuppressive environment. Here, CD300E is linked to breast cancer.